Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child

    Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child
  2. 2

    Trump picks ex-N. Korea policy official as his principal deputy national security adviser

    Trump picks ex-N. Korea policy official as his principal deputy national security adviser
  3. 3

    First snow to fall in Seoul on Wednesday

    First snow to fall in Seoul on Wednesday
  4. 4

    S. Korea not to attend Sado mine memorial: foreign ministry

    S. Korea not to attend Sado mine memorial: foreign ministry
  5. 5

    Wealthy parents ditch Korean passports to get kids into international school

    Wealthy parents ditch Korean passports to get kids into international school
  1. 6

    Man convicted after binge eating to avoid military service

    Man convicted after binge eating to avoid military service
  2. 7

    Toxins at 622 times legal limit found in kids' clothes from Chinese platforms

    Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
  3. 8

    [Weekender] Korea's traditional sauce culture gains global recognition

    [Weekender] Korea's traditional sauce culture gains global recognition
  4. 9

    BLACKPINK's Rose stays at No. 3 on British Official Singles chart with 'APT.'

    BLACKPINK's Rose stays at No. 3 on British Official Singles chart with 'APT.'
  5. 10

    Korea to hold own memorial for forced labor victims, boycotting Japan’s

    Korea to hold own memorial for forced labor victims, boycotting Japan’s
피터빈트

Financial regulator to begin review of Samsung Biologics' alleged accounting fraud

By Yonhap

Published : May 6, 2018 - 16:16

    • Link copied

South Korea's financial regulator said Sunday its accounting oversight panel will hold the first meeting on Samsung Biologics Co.'s alleged violation of accounting rules next week.

The Accounting Oversight Deliberation Committee under the Securities & Futures Commission will hold the meeting on May 17 and review the issue, according to the Financial Service Commission. The SFC, a subcommission of the financial regulator, is responsible for the oversight of the securities and futures markets.

Samsung BioLogics executives speak during an emergency press meeting held on May 2 at the Korea Chamber of Commerce and Industry.(Yonhap) Samsung BioLogics executives speak during an emergency press meeting held on May 2 at the Korea Chamber of Commerce and Industry.(Yonhap)


Last week, the Financial Supervisory Service (FSS) tentatively concluded that the bio unit of Samsung Group has violated accounting rules, adding that corrective measures and punishment may be taken depending on the final outcome.

The bio firm's alleged accounting flaw boils down to whether there were any irregularities over its dramatic business turnaround in 2015. Samsung Biologics, listed on the local stock market in November 2016, reported a net profit of a whopping 1.9 trillion won ($1.76 billion) in 2015, shifting from a loss in the previous four years.

FSC Vice Chairman Kim Yong-beom, who leads the SFC, has asked the deliberation committee to promptly review the matter and submit the results to the SFC.

Accordingly, the financial regulator's final conclusion on the matter could come out on May 23 or June 7 when the SFC's regular meetings are scheduled.

The share price of Samsung Biologics nosedived 26.3 percent over the last three trade sessions, losing a whopping 8.5 trillion won in terms of market cap. (Yonhap)

 

More from Headlines